- Oops!Something went wrong.Please try again later.
MALVERN, Pa. (AP) _ Neuronetics Inc. (STIM) on Tuesday reported a loss of $7.5 million in its first quarter.
On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 42 cents.
The medical device company focused on psychiatric disorders posted revenue of $12.7 million in the period.
For the current quarter ending in July, Neuronetics said it expects revenue in the range of $15.6 million to $16.2 million.
The company expects full-year revenue in the range of $62.5 million to $64.5 million.
Neuronetics shares have declined 11% since the beginning of the year.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on STIM at https://www.zacks.com/ap/STIM